
Alphabet life science subsidiary Verily raises $1 billion to expand
Verily, a life science subsidiary of Alphabet, raised $1 billion in a recent funding round to support the business’s expansion. The research group was founded in 2015 to improve precision health. Its primary objective is to use data from a wide range of clinical, social, and behavioural source... Read more